Form 8-K - Current report:
SEC Accession No. 0001104659-25-034210
Filing Date
2025-04-11
Accepted
2025-04-11 16:09:11
Documents
15
Period of Report
2025-04-10
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2512021d1_8k.htm   iXBRL 8-K 24123
2 EXHIBIT 10.1 tm2512021d1_ex10-1.htm EX-10.1 12302
6 GRAPHIC tm2512021d1_ex10-1img001.jpg GRAPHIC 10642
  Complete submission text file 0001104659-25-034210.txt   226491

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA kala-20250410.xsd EX-101.SCH 3008
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE kala-20250410_lab.xml EX-101.LAB 34239
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE kala-20250410_pre.xml EX-101.PRE 22354
17 EXTRACTED XBRL INSTANCE DOCUMENT tm2512021d1_8k_htm.xml XML 3566
Mailing Address 1167 MASSACHUSETTS AVENUE ARLINGTON MA 02476
Business Address 1167 MASSACHUSETTS AVENUE ARLINGTON MA 02476 781-996-5252
KALA BIO, Inc. (Filer) CIK: 0001479419 (see all company filings)

EIN.: 270604595 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38150 | Film No.: 25832163
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)